Migration-stimulating factor (MSF) is over-expressed in non-small cell lung cancer and promotes cell migration and invasion in A549 cells over-expressing MSF

Experimental Cell Research

Volumn 319, Issue 17, 2013, Pages 2545-2553

  Deng, Xuefeng ^a,b   Ma, Qunfeng ^b   Zhang, Bo ^b   Jiang, Hong ^c   Zhang, Zhipei ^a   Wang, Yunjie ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c BEIJING JIAOTONG UNIVERSITY   (China)

Author keywords

Fibronectin; Invasion; Matrix metalloprotease (MMP); Migration; Migration stimulating factor (MSF); Non small cell lung cancer (NSCLC)

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FIBRONECTIN; GELATINASE A; GELATINASE B; MESSENGER RNA; MIGRATION STIMULATING FACTOR;

ADULT; ARTICLE; CANCER STAGING; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION;

EID: 84885382035     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.05.016     Document Type: Article

References (28)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62(2012):10-29.
2. Chen W.Q., Zheng R.S., Zeng H.M., Zhang S.W., Zhao P., He J. Trend analysis and projection of cancer incidence in China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi 2012, 34:517-524.
3. Kay R.A., Ellis I.R., Jones S.J., Perrier S., Florence M.M., Schor A.M., Schor S.L. The expression of MSF, a potent oncofetal cytokine, is uniquely controlled by 3'-untranslated region dependent nuclear sequestration of its precursor messenger RNA. Cancer Res. 2005, 65:10742-10749.
4. Schor S.L., Ellis I.R., Jones S.J., Baillie R., Seneviratne K., Clausen J., Motegi K., Schor A.M. Migration-stimulating factor: a genetically truncated oncofetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Res. 2003, 63:8827-8836.
5. Schor S.L., Schor A.M., Keatch R.P., Belch J.J.F. Role of matrix macromolecules in the aetiology and treatment of chronic ulcers. The Wound Healing Management Manual 2005, 109-121. Bok Y Lee, New York, Chapter 10.
6. Hu H., Ran Y., Zhang Y., Zhou Z., Harris S.J., Yu L., Sun L., Pan J., Liu J., Lou J., Yang Z.H. Antibody library-base tumor endothelial cells surface proteomic functional screen reveals migration stimulating factor as an anti-angiogenic target. Mol. Cell Proteomics 2009, 8:816-826.
7. Aljorani L.E., Bankfalvi A., Carey F.A., Harada K., Ohe G., Jones S.J., Ellis I.R., Schor S.L., Schor A.M. Migration-stimulating factor as a novel biomarker in salivary gland tumours. J. Oral Pathol. Med. 2011, 40:747-754.
8. Schor A.M., Schor S.L. Angiogenesis and tumor progression. Migration-stimulating factor as a novel target for clinical intervention. Eye (London) 2010, 24:450-458.
9. Houard X., Germain S., Gervais M., Michaud A., Foidart J.M., Monnot C., Corvol P. Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration. Int. J. Cancer 2005, 116:378-384.
10. Carito V., Bonuccelli G., Martinez-outschoorn U.E., Whitaker-Menezes D., Caroleo M.C., Cione E., Howell A., Pestell R.G., Lisanti M.P., Sotgia F. Migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth. Cell Cycle 2012, 18:3403-3414.
11. Schor S.L., Ellis I.R., Jones S.J., Woolston A.M., Schor A.M. Bistable switch in migration stimulating factor expression: regulation by the concerted signalling of transforming growth factor-β1 and the extracellular matrix. Int. J. Cancer 2012, 130:2024-2032.
12. Solinas G., Schiarea S., Liguori M., Fabbri M., Pesce S., Zammataro L., Mantovani A., Allavena P. Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J. Immunol. 2010, 185:642-652.
13. Yoshino I., Kometani T., Shoji F., Osoegawa A., Ohba T., Kouso H., Takenaka T., Yonena T., Maehara Y. Induction of epithelial-mesenchymal transition-related genes by benzo(a)pyrene in lung cancer cells. Cancer 2007, 110:369-374.
14. Slaughter D.P., Southwick H.W., Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer 1953, 6:963-968.
15. Gomperts B.N., Spira A., Massion P.P., Walser T.C., Wistuba I.I., Minna J.D., Dubinett S.M. Evolving concepts in lung carcinogenesis. Semin. Respir. Crit. Care Med. 2011, 32:32-43.
16. Franklin W.A., Gazdar A.F., Haney J., Wistuba I.I., La Rosa F.G., Kennedy T., Ritchey D.M., Miller Y.E. Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J. Clin. Invest. 1997, 100:2133-2137.
17. Munshi H.G., Stack M.S. Reciprocal interactions between adhesion receptor signaling and MMP regulation. Cancer Metastasis Rev. 2006, 25:45-56.
18. Ghosh S., Wu Y., Stack M.S. Ovarian cancer-associated proteinases. Cancer Treat. Res. 2002, 107:331-351.
19. Liotta L.A., Steeg P.S., Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64:327-336.
20. Jovanović M., Stefanoska I., Radojcić L., Vićovac L. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase MMP-2 and MMP-9 and integrins alpha5 and beta1. Reproduction 2010, 139:789-798.
21. Hung W.C., Tseng W.L., Shiea J., Chang H.C. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett. 2010, 288:156-161.
22. Littlepage L.E., Sternlicht M.D., Rougier N., Phillips J., Gallo E., Yu Y., Williams K., Brenot A., Gordon J.I., Werb Z. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res. 2010, 70:2224-2234.
23. Park J.K., Park S.H., So K., Bae I.H., Yoo Y.D., Um H.D. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int. J. Oncol. 2010, 36:181-192.
24. Merkle M., Ribeiro A., Sauter M., Ladurner R., Mussack T., Sitter T., Wörnle M. Effect of activation of viral receptors on the gelatinases MMP-2 and MMP-9 in human mesothelial cells. Matrix Biol. 2010, 29:202-208.
25. Sodek K.L., Brown T.J., Ringuette M.J. Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration. BMC Cancer 2008, 8:223-233.
26. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 2003, 3:362-374.
27. Friedl P., Alexander S. Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 2011, 147:992-1009.
28. Wolf K., Mazo I., Leung H., Engelke K., von Andrian U.H., Deryugina E.I., Strongin A.Y., Brocker E.B., Friedl P. Compensation mechanism in tumor cell migration: mesenchymal-ameboid transition after blocking of pericellular proteolysis. J. Cell Biol. 2003, 160:267-277.